Veradermics Registers 17.07M Shares for Resale by Stockholders
Veradermics, Inc. filed an S-1 Registration Statement to register up to 17,072,058 shares of common stock for resale by existing selling stockholders. This includes 16,772,058 shares of common stock and 300,000 shares issuable upon the exercise of pre-funded warrants, representing approximately 40.6% of the company's total outstanding common stock. While the company will not receive proceeds from the resale, it may receive proceeds from the cash exercise of warrants, following a recent $30.0 million private placement.
Key Highlights
- Veradermics registered 17,072,058 common shares for resale by stockholders.
- Includes 300,000 shares issuable upon exercise of Pre-Funded Warrants.
- Resale shares represent approximately 40.6% of total outstanding common stock.
- Company will not receive proceeds from the resale of shares.
- Proceeds may be received from cash exercise of Pre-Funded Warrants.
- A May 2026 private placement raised $30.0 million from Pre-Funded Warrants.
- Common stock traded at $108.65 on August 6, 2026.
- Developing VDPHL01, an oral treatment for pattern hair loss.
Price Impact
More from MANE
Veradermics VDPHL01 Phase 2 trial positive; 22.7-23.3 hairs/cm² increase
Veradermics Raises $767M+ via IPO, Follow-On & Private Placement
Veradermics VDPHL01 Phase 2/3 Positive; Raises $766.8M; Q1 Net Loss $27.2M